Canada markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
293.85-1.88 (-0.64%)
At close: 04:00PM EDT
293.85 0.00 (0.00%)
After hours: 04:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.36B
Enterprise Value 8.11B
Trailing P/E N/A
Forward P/E 27.17
PEG Ratio (5 yr expected) 1.07
Price/Sales (ttm)3.29
Price/Book (mrq)0.93
Enterprise Value/Revenue 3.11
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3-24.10%
S&P500 52-Week Change 326.49%
52 Week High 3431.79
52 Week Low 3261.59
50-Day Moving Average 3308.90
200-Day Moving Average 3328.27

Share Statistics

Avg Vol (3 month) 3213.82k
Avg Vol (10 day) 3215.24k
Shares Outstanding 523.45M
Implied Shares Outstanding 628.57M
Float 819.97M
% Held by Insiders 115.23%
% Held by Institutions 179.99%
Shares Short (Apr 30, 2024) 4733.05k
Short Ratio (Apr 30, 2024) 43.47
Short % of Float (Apr 30, 2024) 44.10%
Short % of Shares Outstanding (Apr 30, 2024) 42.57%
Shares Short (prior month Mar 28, 2024) 4564.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 08, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -12.37%
Operating Margin (ttm)8.48%

Management Effectiveness

Return on Assets (ttm)1.69%
Return on Equity (ttm)-3.43%

Income Statement

Revenue (ttm)2.61B
Revenue Per Share (ttm)90.02
Quarterly Revenue Growth (yoy)-9.80%
Gross Profit (ttm)N/A
EBITDA 502.99M
Net Income Avi to Common (ttm)-322.37M
Diluted EPS (ttm)-10.68
Quarterly Earnings Growth (yoy)456.70%

Balance Sheet

Total Cash (mrq)1.65B
Total Cash Per Share (mrq)57.69
Total Debt (mrq)1.4B
Total Debt/Equity (mrq)15.47%
Current Ratio (mrq)6.57
Book Value Per Share (mrq)317.32

Cash Flow Statement

Operating Cash Flow (ttm)346.57M
Levered Free Cash Flow (ttm)120.82M